• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

生存促进信号调节脂噬对于多发性骨髓瘤抵抗应激诱导死亡是必需的。

Pro-survival signaling regulates lipophagy essential for multiple myeloma resistance to stress-induced death.

机构信息

Department of Immunology, Roswell Park Comprehensive Cancer Center, Buffalo, NY, USA.

Department of Pediatrics, State University of New York at Buffalo, Buffalo, NY, USA.

出版信息

Cell Rep. 2024 Jul 23;43(7):114445. doi: 10.1016/j.celrep.2024.114445. Epub 2024 Jul 4.

DOI:10.1016/j.celrep.2024.114445
PMID:38968073
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11318075/
Abstract

Pro-survival metabolic adaptations to stress in tumorigenesis remain less well defined. We find that multiple myeloma (MM) is unexpectedly dependent on beta-oxidation of long-chain fatty acids (FAs) for survival under both basal and stress conditions. However, under stress conditions, a second pro-survival signal is required to sustain FA oxidation (FAO). We previously found that CD28 is expressed on MM cells and transduces a significant pro-survival/chemotherapy resistance signal. We now find that CD28 signaling regulates autophagy/lipophagy that involves activation of the Ca→AMPK→ULK1 axis and regulates the translation of ATG5 through HuR, resulting in sustained lipophagy, increased FAO, and enhanced MM survival. Conversely, blocking autophagy/lipophagy sensitizes MM to chemotherapy in vivo. Our findings link a pro-survival signal to FA availability needed to sustain the FAO required for cancer cell survival under stress conditions and identify lipophagy as a therapeutic target to overcome treatment resistance in MM.

摘要

肿瘤发生中的生存代谢适应对压力的适应仍不太明确。我们发现,多发性骨髓瘤(MM)在基础和应激条件下出乎意料地依赖于长链脂肪酸(FA)的β氧化来生存。然而,在应激条件下,需要第二个生存信号来维持 FA 氧化(FAO)。我们之前发现 CD28 在 MM 细胞上表达,并传递显著的生存/化疗耐药信号。我们现在发现 CD28 信号转导调节自噬/脂噬,涉及 Ca→AMPK→ULK1 轴的激活,并通过 HuR 调节 ATG5 的翻译,导致持续的脂噬、增加的 FAO 和增强的 MM 生存。相反,阻断自噬/脂噬使 MM 在体内对化疗敏感。我们的发现将生存信号与 FA 的可利用性联系起来,FA 是在应激条件下维持癌症细胞生存所需的 FAO 所必需的,并将脂噬鉴定为克服 MM 治疗耐药性的治疗靶点。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a09e/11318075/776b200538c0/nihms-2011879-f0008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a09e/11318075/88a4b004aa67/nihms-2011879-f0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a09e/11318075/56ca490dcdb3/nihms-2011879-f0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a09e/11318075/b50949c9ec31/nihms-2011879-f0004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a09e/11318075/13142dc3e873/nihms-2011879-f0005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a09e/11318075/dda4077c21ef/nihms-2011879-f0006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a09e/11318075/69cb4ceab337/nihms-2011879-f0007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a09e/11318075/776b200538c0/nihms-2011879-f0008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a09e/11318075/88a4b004aa67/nihms-2011879-f0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a09e/11318075/56ca490dcdb3/nihms-2011879-f0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a09e/11318075/b50949c9ec31/nihms-2011879-f0004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a09e/11318075/13142dc3e873/nihms-2011879-f0005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a09e/11318075/dda4077c21ef/nihms-2011879-f0006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a09e/11318075/69cb4ceab337/nihms-2011879-f0007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a09e/11318075/776b200538c0/nihms-2011879-f0008.jpg

相似文献

1
Pro-survival signaling regulates lipophagy essential for multiple myeloma resistance to stress-induced death.生存促进信号调节脂噬对于多发性骨髓瘤抵抗应激诱导死亡是必需的。
Cell Rep. 2024 Jul 23;43(7):114445. doi: 10.1016/j.celrep.2024.114445. Epub 2024 Jul 4.
2
MIR4726 drives bortezomib resistance in multiple myeloma by enhancing MIR4726-5p/NXF1/NKIRAS2 axis dependent autophagy.MIR4726通过增强MIR4726-5p/NXF1/NKIRAS2轴依赖性自噬驱动多发性骨髓瘤对硼替佐米的耐药性。
Cell Commun Signal. 2025 Jul 18;23(1):346. doi: 10.1186/s12964-025-02340-7.
3
Inhibition of CD36 ameliorates mouse spinal cord injury by accelerating microglial lipophagy.抑制CD36可通过加速小胶质细胞脂质自噬改善小鼠脊髓损伤。
Acta Pharmacol Sin. 2025 May;46(5):1205-1220. doi: 10.1038/s41401-024-01463-w. Epub 2025 Jan 29.
4
Loss of GABARAP mediates resistance to immunogenic chemotherapy in multiple myeloma.GABARAP 的缺失介导多发性骨髓瘤对免疫化疗的耐药性。
Blood. 2024 Jun 20;143(25):2612-2626. doi: 10.1182/blood.2023022777.
5
Targeting the HuR/E2F7 axis synergizes with bortezomib against multiple myeloma.靶向HuR/E2F7轴与硼替佐米协同作用对抗多发性骨髓瘤。
Acta Pharmacol Sin. 2025 Mar 25. doi: 10.1038/s41401-025-01529-3.
6
Orthogonal targeting of osteoclasts and myeloma cells for radionuclide stimulated dynamic therapy induces multidimensional cell death pathways.成骨细胞和骨髓瘤细胞的正交靶向放射性核素刺激动态治疗诱导多维细胞死亡途径。
Theranostics. 2021 Jun 22;11(16):7735-7754. doi: 10.7150/thno.60757. eCollection 2021.
7
Heme promotes venetoclax resistance in multiple myeloma through MEK-ERK signaling and purine biosynthesis.血红素通过MEK-ERK信号传导和嘌呤生物合成促进多发性骨髓瘤对维奈托克耐药。
Blood. 2025 Feb 13;145(7):732-747. doi: 10.1182/blood.2024025690.
8
CALR regulates the proliferation and drug sensitivity of multiple myeloma cells through the BCL2 signaling pathway.钙网蛋白通过BCL2信号通路调节多发性骨髓瘤细胞的增殖和药物敏感性。
Mol Biol Rep. 2025 Jul 1;52(1):664. doi: 10.1007/s11033-025-10749-z.
9
Inhibition of CDC27 O-GlcNAcylation coordinates the antitumor efficacy in multiple myeloma through the autophagy-lysosome pathway.抑制CDC27的O-连接N-乙酰葡糖胺化通过自噬-溶酶体途径协同发挥对多发性骨髓瘤的抗肿瘤作用。
Acta Pharmacol Sin. 2025 Feb 21. doi: 10.1038/s41401-025-01500-2.
10
RAN contributes to bortezomib resistance in multiple myeloma via regulating the Wnt/PCP pathway.RAN通过调节Wnt/PCP信号通路促进多发性骨髓瘤对硼替佐米的耐药性。
Neoplasma. 2025 Jun;72(3):153-163. doi: 10.4149/neo_2025_250207N65.

引用本文的文献

1
RAB5 NUCLEOTIDE BINDING PROMOTES β-OXIDATION TO FUEL HEPATOCELLULAR CARCINOMA CELL PROLIFERATION.RAB5核苷酸结合促进β-氧化以支持肝癌细胞增殖。
bioRxiv. 2025 Aug 24:2025.08.20.670915. doi: 10.1101/2025.08.20.670915.

本文引用的文献

1
Targeting the fatty acid binding proteins disrupts multiple myeloma cell cycle progression and MYC signaling.靶向脂肪酸结合蛋白会扰乱多发性骨髓瘤细胞周期进程和 MYC 信号转导。
Elife. 2023 Mar 7;12:e81184. doi: 10.7554/eLife.81184.
2
PD-1 signaling facilitates activation of lymphoid tissue inducer cells by restraining fatty acid oxidation.PD-1 信号通过抑制脂肪酸氧化促进淋巴组织诱导细胞的激活。
Nat Metab. 2022 Jul;4(7):867-882. doi: 10.1038/s42255-022-00595-9. Epub 2022 Jul 4.
3
Multiple myeloma: 2022 update on diagnosis, risk stratification, and management.
多发性骨髓瘤:2022 年诊断、风险分层和治疗的更新。
Am J Hematol. 2022 Aug;97(8):1086-1107. doi: 10.1002/ajh.26590. Epub 2022 May 23.
4
The regulation, function, and role of lipophagy, a form of selective autophagy, in metabolic disorders.脂噬作用(一种选择性自噬形式)在代谢紊乱中的调节、功能和作用。
Cell Death Dis. 2022 Feb 8;13(2):132. doi: 10.1038/s41419-022-04593-3.
5
Myeloid antigen-presenting cell niches sustain antitumor T cells and license PD-1 blockade via CD28 costimulation.髓系抗原呈递细胞龛位通过 CD28 共刺激维持抗肿瘤 T 细胞并许可 PD-1 阻断。
Cancer Cell. 2021 Dec 13;39(12):1623-1642.e20. doi: 10.1016/j.ccell.2021.10.008. Epub 2021 Nov 4.
6
Multiple myeloma cells induce lipolysis in adipocytes and uptake fatty acids through fatty acid transporter proteins.多发性骨髓瘤细胞通过脂肪酸转运蛋白诱导脂肪细胞脂解并摄取脂肪酸。
Blood. 2022 Feb 10;139(6):876-888. doi: 10.1182/blood.2021013832.
7
ULK1 inhibition overcomes compromised antigen presentation and restores antitumor immunity in LKB1 mutant lung cancer.ULK1抑制可克服LKB1突变型肺癌中受损的抗原呈递并恢复抗肿瘤免疫。
Nat Cancer. 2021 May;2(5):503-514. doi: 10.1038/s43018-021-00208-6. Epub 2021 May 17.
8
Fatty Acid Oxidation Is an Adaptive Survival Pathway Induced in Prostate Tumors by HSP90 Inhibition.脂肪酸氧化是 HSP90 抑制诱导前列腺肿瘤产生的适应性生存途径。
Mol Cancer Res. 2020 Oct;18(10):1500-1511. doi: 10.1158/1541-7786.MCR-20-0570. Epub 2020 Jul 15.
9
CD28 Regulates Metabolic Fitness for Long-Lived Plasma Cell Survival.CD28 调节代谢适应性以延长浆细胞存活时间。
Cell Rep. 2020 Jun 23;31(12):107815. doi: 10.1016/j.celrep.2020.107815.
10
CD36-Mediated Metabolic Rewiring of Breast Cancer Cells Promotes Resistance to HER2-Targeted Therapies.CD36 介导的乳腺癌细胞代谢重编程促进对 HER2 靶向治疗的耐药性。
Cell Rep. 2019 Dec 10;29(11):3405-3420.e5. doi: 10.1016/j.celrep.2019.11.008.